NCT07054944Not yet recruiting
Tumor-Lymph Node Mapping
FEASIBILITY AND SAFETY OF INDOCYANINE GREEN (ICG) GUIDED SENTINEL LYMPH NODE MAPPING FOR PEDIATRIC SOLID TUMORS - T-LyM (Tumor-Lymph Node Mapping)
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 10 (estimated)
- First submitted
- 18 Jun 2025
- Start date
- Dec 2026
- Primary completion date
- Jul 2028
- Lead sponsor
- University of Rochester
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT07054944
What you commit to
- Study type: Observational
- Planned participants: 10
- From Dec 2026 to the primary completion date, Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with extensive prior surgery at the primary site or nodal basin expected to affect the lymphatic drainage.
Other illness
- Subjects with a history of iodide allergies.
Other
- Inability or unwillingness of research participant or parent/legal guardian to give written informed consent.
- Currently pregnant.
- Infants under 650 grams.
Who the study is looking for
- Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery.
- Diagnosed with pediatric solid tumor
- Scheduled to undergo lymph node sampling as part of their clinical management.
Age in the registry: 1 month to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Medical Center Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.